These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14670928)

  • 1. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.
    Hirsch B; Shimamura A; Moreau L; Baldinger S; Hag-alshiekh M; Bostrom B; Sencer S; D'Andrea AD
    Blood; 2004 Apr; 103(7):2554-9. PubMed ID: 14670928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations.
    Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA
    Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
    Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
    Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.
    Reid S; Renwick A; Seal S; Baskcomb L; Barfoot R; Jayatilake H; Pritchard-Jones K; Stratton MR; Ridolfi-Lüthy A; Rahman N; ;
    J Med Genet; 2005 Feb; 42(2):147-51. PubMed ID: 15689453
    [No Abstract]   [Full Text] [Related]  

  • 6. Fanconi anemia and solid malignancies in childhood: a national retrospective study.
    Malric A; Defachelles AS; Leblanc T; Lescoeur B; Lacour B; Peuchmaur M; Maurage CA; Pierron G; Guillemot D; d'Enghien CD; Soulier J; Stoppa-Lyonnet D; Bourdeaut F
    Pediatr Blood Cancer; 2015 Mar; 62(3):463-70. PubMed ID: 25381700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
    Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
    J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
    Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
    Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.
    Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A
    Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
    Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications.
    Dodgshun AJ; Sexton-Oates A; Saffery R; Sullivan MJ
    Cancer Genet; 2016; 209(1-2):53-6. PubMed ID: 26740091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-linker-sensitive myeloid leukemia cell line from a 2-year-old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations.
    Meyer S; Fergusson WD; Oostra AB; Medhurst AL; Waisfisz Q; de Winter JP; Chen F; Carr TF; Clayton-Smith J; Clancy T; Green M; Barber L; Eden OB; Will AM; Joenje H; Taylor GM
    Genes Chromosomes Cancer; 2005 Apr; 42(4):404-15. PubMed ID: 15645491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.
    Miele E; Mastronuzzi A; Po A; Carai A; Alfano V; Serra A; Colafati GS; Strocchio L; Antonelli M; Buttarelli FR; Zani M; Ferraro S; Buffone A; Vacca A; Screpanti I; Giangaspero F; Giannini G; Locatelli F; Ferretti E
    Biomark Res; 2015; 3():13. PubMed ID: 26064523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review.
    Freycon C; Sepulchre E; Lavallée VP; Mitchell D; MacMillan ML; Vezina C; Goudie C
    Clin Genet; 2024 Aug; 106(2):193-198. PubMed ID: 38658784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.
    Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J
    Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene.
    Degrolard-Courcet E; Sokolowska J; Padeano MM; Guiu S; Bronner M; Chery C; Coron F; Lepage C; Chapusot C; Loustalot C; Jouve JL; Hatem C; Ferrant E; Martin L; Coutant C; Baurand A; Couillault G; Delignette A; El Chehadeh S; Lizard S; Arnould L; Fumoleau P; Callier P; Mugneret F; Philippe C; Frebourg T; Jonveaux P; Faivre L
    Eur J Hum Genet; 2014 Aug; 22(8):979-87. PubMed ID: 24301060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood.
    Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL
    Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.
    Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H
    Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple synchronous tumors in a child with Fanconi anemia.
    Compostella A; Toffolutti T; Soloni P; Dall'Igna P; Carli M; Bisogno G
    J Pediatr Surg; 2010 Feb; 45(2):e5-8. PubMed ID: 20152336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.